sj-docx-2-tag-10.1177_17562848231174953 – Supplemental material for Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study

Autor:	Visuri, Isabella, Eriksson, Carl, Karlqvist, Sara, Lykiardopoulos, Byron, Karlén, Per, Grip, Olof, Söderman, Charlotte, Almer, Sven, Hertervig, Erik, Marsal, Jan, Malmgren, Carolina, Delin, Jenny, Strid, Hans, Sjöberg, Mats, Bergemalm, Daniel, Hjortswang, Henrik, Halfvarson, Jonas
Rok vydání:	2023
Předmět:	FOS: Clinical medicine 111199 Nutrition and Dietetics not elsewhere classified FOS: Health sciences 111599 Pharmacology and Pharmaceutical Sciences not elsewhere classified 111299 Oncology and Carcinogenesis not elsewhere classified
ISSN:	1756-2848
DOI:	10.25384/sage.23268037.v1
Popis:	Supplemental material, sj-docx-2-tag-10.1177_17562848231174953 for Long-term outcomes of vedolizumab in inflammatory bowel disease: the Swedish prospective multicentre SVEAH extension study by Isabella Visuri, Carl Eriksson, Sara Karlqvist, Byron Lykiardopoulos, Per Karlén, Olof Grip, Charlotte Söderman, Sven Almer, Erik Hertervig, Jan Marsal, Carolina Malmgren, Jenny Delin, Hans Strid, Mats Sjöberg, Daniel Bergemalm, Henrik Hjortswang and Jonas Halfvarson in Therapeutic Advances in Gastroenterology
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::6394d8d707129a4dd79f95b07c00f9f9 Zobrazit plný text záznamu